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Abstract 
In the last two decades adiponectin, member of the adipokines family, gained attention because of its 
unique antidiabetic effects. However, the presence in the brain of adiponectin receptors and adiponectin 
itself raised interest because of the possible association with neuropsychiatric diseases. Indeed, clinical 
studies found altered concentration of adiponectin both in plasma and cerebrospinal fluid in seeveral 
pathologies including depression, multiple sclerosis, Alzheimer’s disease and stroke. Moreover, recent 
preclinical studies also suggest its involvement in different physiological functions. Despite this evidence 
very few studies attempted to elucidate the functional role of adiponectin at the synapse.To address this 
question, here we investigated the effect of Adiporon, an agonist of both adiponectin receptors on synaptic 
transmission and LTP at Schaffer-collateral CA1 pathway. Surprisingly, increasing concentration of Adiporon 
correlated with lower CA1-LTP levels and paired-pulse ratio, whereas basal transmission was always 
preserved. Collectively, our data show that the adiponectin system, beyond its involvement in metabolic 
diseases, plays also a critical role in synaptic activity thereby representing a putative target for the 
treatment of synaptic pathologies.  
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 INTRODUCTION 
Adiponectin, a member of the Adipokine family, has sparked new enthusiasm in the field of metabolic 
diseases and paved the way for a new generation of drugs affecting metabolism (Okada-Iwabu et al., 2015). 
In fact, a key role of adiponectin in several metabolic and inflammatory disorders has recently emerged. 
Accordingly, plasma adiponectin levels were found decreased in obesity, insulin resistance, and type 2 
diabetes (Kadowaki et al., 2006). Moreover, adiponectin exerts a protective role in several pathologies, 
such as cardiovascular diseases, cancer, and appears also to promote longevity (Yamauchi and Kadowaki, 
2013). However, after the discovery of adiponectin in human cerebrospinal fluid (Kos et al., 2007), the 
adiponectin system gained attention and several clinical studies suggested a role in neuropsychiatric 
diseases, such as depression (Leo et al., 2006; Narita et al., 2006), cognitive impairment associated with 
diabetes (Masaki et al., 2012; Gorska-Ciebiada et al., 2015), Alzheimer’s disease (Teixeira et al., 2013), 
stroke (Sasaki et al., 2007), multiple sclerosis (Musabak et al., 2010) and attention deficit hyperactivity 
disorder (Mavroconstanti et al., 2014). In particular, those studies have all reported lower circulating levels 
of adiponectin. Adiponectin is an adipocyte-derived polypeptide released into the circulation in the 
configuration of full-length trimers, hexamers, high molecular weight (HMW) multimers and a globular 
fraction called globular adiponectin (gAD), generated by proteolytic cleavage of the full-length protein 
(Waki et al., 2005). Surprisingly this protein is one of the most abundant, representing 0.05% of total 
plasma proteins (Scherer et al., 1995). Adiponectin exerts its effects by binding three receptors. Two of 
them, adipoR1 and adipoR2, are integral membrane proteins with seven transmembrane domains (7TM). 
However, these receptors possess an intracellular amino terminus and an extracellular carboxyl-terminus 
which renders them a novel structural class (Tanabe et al., 2015). The third receptor is T-cadherin which is 
also an LDL receptor. The transduction pathways of adipoR1 and 2 culminate in the activation of AMPK and 
PPARα while T-cadherin acts in an unknown way (Wang and Scherer, 2016). Despite mounting evidence of 
adiponectin involvement in many neuropsychiatric diseases which show a synaptic pathology (Ganguly and 
Poo, 2013), their physiological role in the synapse remains elusive. One experimental difficulty could be 
represented by the fact that, for the majority of relevant functions, both the principal receptors must be 
activated simultaneously (Yamauchi et al., 2007). On other hand, adipoR1 and 2 show divergent Kd values 
for different adiponectin forms (Yamauchi and Kadowaki, 2013). As the receptors are highly expressed in 
hippocampus (Repunte-canonigo et al., 2011; Thundyil et al., 2012) we employed a selective agonist for 
adipoR1\2  (Adiporon, ADPO) with similar Kd values for both receptors(Okada-Iwabu et al., 2013). In this 
way, we were able to activate simultaneously both receptors and study their functional role in synaptic 
transmission and neuroplasticity at CA1 hippocampal synapses. 
MATERIALS AND METHODS 
Animals  
Experiments were carried out in accordance with the guidelines established by the European Communities 
Council (Directive 2010/63/EU of 22 September 2010) and accepted by the Italian Ministry of Health (D.Lgs. 
26/2014) and approved by the Ethical Committee on animal experiments of Santa Lucia Foundation (Rome, 
Italy). Two- to four-week-old male C57BL/6J mice (Young group) and five-to eight-week-old male C57BL/6J 
mice (Adult group) were used for all experiments. 
Electrophysiology 
Preparation of mouse brain slices was performed as previously described (Nisticò et al., 2013). Parasagittal 
hippocampal slices (thickness, 250–350 μm) were cut using a Vibratome (Leica VT1000 S) and incubated for 
1 h in a holding chamber and then transferred to a recording chamber, completely submerged in artificial 
cerebrospinal fluid (ACSF, 30–31°C) of the following composition (in mM): NaCl (124), KCl (3), MgCl2 (1), 
CaCl2 (2), NaH2PO4 (1.25), NaHCO3 (26), glucose (10); saturated with 95% O2, 5% CO2. For extracellular 
recordings, bipolar stimulating electrode was placed in the stratum radiatum to activate the Schaffer 
collateral commissural fibers. Recordings of field excitatory postsynaptic potentials (fEPSPs) were made in 
the middle of the stratum radiatum by using microelectrodes filled with ACSF (resistance 3–5 MΩ). For 
slices in which the presynaptic fiber volley was distinguishable, input-output curves were examined by 
plotting the initial slope of the fEPSP against the amplitude of the presynaptic fiber volley. Long-term 
potentiation (LTP) was induced by high-frequency stimulation (HFS; 100 Hz, duration 1 s). 
Drug Treatments 
Adiporon (ADPO; Sigma) was dissolved in dimethyl sulfoxide (DMSO), prepared as stock solutions and 
diluted to the final concentration immediately before use. Final concentrations were as follows: ADPO (1.5, 
3, 30 µM). DMSO was used both in treated and in vehicle groups and the final concentration of DMSO was 
less than 0.5% in all experiments. Incubation of hippocampal slices with drugs was performed in an 
incubation chamber. The pre-incubated treated and vehicle slices were held in ACSF with or without several 
concentration of ADPO for 1.5-2 hours before recordings. 
Statistical Analysis 
For statistical analysis we used unpaired t test after LTP induction (on the average of the last 10 min of 
recording). The overall depolarization during HFS has been quantified using a slightly modified   method 
(Kuenzi et al., 2000) by measuring the area under the curve (AUC) during the 100 Hz train stimulus using as 
y value the baseline and normalising each obtained AUC to the first fEPSP in each train. All data are 
presented as mean ± SEM, and ‘‘n’’ indicates the number of slices. P < 0.05 was considered significant. 
RESULTS  
Adiporon affects paired pulse ratio but does not influence basal synaptic transmission 
After 20 min of stable baseline recordings, consecutive application of increasing concentrations of ADPO 
(1.5, 3, 30 μM) for 15 minutes did not modify basal synaptic transmission (data not shown). In a subset of 
experiments, we delivered a tetanic stimulation to Schaffer collaterals (100 Hz, 1 sec) following perfusion of 
ADPO. Although some increase in LTP magnitude was present, it did not reach statistical significance (data 
not shown). Since adiponectin receptors display a slow activation rate upon agonist exposure on a time 
scale of minutes to hours (Qiu et al., 2011; Song et al., 2013; Shah et al., 2014), we then evaluated ADPO 
effects after pre-incubating slices for 2 hours with increasing concentrations (1.5, 3, 30 µM). ADPO effect 
was always evaluated in hippocampal slices from young (two- to four-week-old) and adult (five- to eight-
week-old) male C57BL/6J mice, since the mechanisms underlying synaptic transmission differ at the two 
age stages (Lohmann and Kessels, 2014). We then performed a paired pulse ratio (PPR) protocol to assess 
the paired pulse facilitation, which represents a form of short-term plasticity that occurs through 
presynaptic mechanisms and mirrors presynaptic release probability (Zucker and Regehr, 2002). A decrease 
in the PPR was present when ADPO was perfused at the concentration of 30 µM (p < 0.05 at all intervals; 
fig.1A,B) suggesting an increase in the release probability in both experimental groups. However, at the 
concentration of 1.5 and 3 µM, ADPO did not significantly modify the PPR (p > 0.05; fig.1A,B). Next, we 
performed an input-output curve analysis to investigate whether the reduction in PPR was accompanied by 
some changes in basal excitatory transmission. Surprisingly, none of tested concentrations of ADPO (1.5, 3, 
30 µM) significantly affected the input-output curve at both ages groups (p > 0.05; fig.1C,D). The latter data 
suggest that, despite a change in PPR at the highest ADPO tested concentration (30 µM), the amplitude of 
fEPSPs  was always preserved. 
Dose-dependent effect of Adiporon on CA1-LTP  
Following the investigation on the effects of ADPO on PPR and baseline transmission, we next evaluated 
LTP, a widely recognized model that underlies the synaptic basis of memory (Bliss and Collingridge, 1993). 
In a subset of experiments hippocampal slices were pre-incubated for 2 hours with different concentrations 
of ADPO (1.5, 3, 30 µM) and after obtaining a stable baseline, we delivered HFS protocol to Schaffer 
collaterals. Both age groups showed a marked reduction in LTP at the highest tested concentration of ADPO 
(30 µM) (fig.2A,B). However, the young age-group seemed less prone to ADPO’s dampening effect on LTP 
compared to the adult group. Indeed, in the young group, meanwhile we still find a strong effect of ADPO 
on the PPR, the ADPO’s capability to inhibit LTP was low at the highest tested concentration (30 µM) 
(vehicle 47±4% vs. ADPO 24±4%, p < 0.05; fig.2A) and tended to decrease at a lower concentration (3 µM) 
(vehicle 47±4% vs. ADPO 44±3%, p > 0.05; fig2A), until no inhibitory effect on LTP was observed at 1.5 µM 
(p > 0.05, data not shown). On the other hand, in the adult age-group, at the highest tested concentration 
of ADPO (30 µM), LTP was almost abolished (vehicle 46±2% vs. ADPO 7±3%, p < 0.01; fig.2B). This effect 
faded with lower concentrations with a reduction of LTP of approximately 50% at 3 µM (vehicle 46±2 % vs. 
ADPO 21±2 %, p < 0.05; fig.2B), until it disappeared at 1.5 µM (p> 0.05, data not shown). Notably, in the 
adult age-group, meanwhile the dampening effect on LTP was concentration-dependent, the reduction in 
PPR was apparent only at higher concentration (30µM). Moreover, ADPO concentration of 3 µM , that still 
maintained an inhibitory effect on LTP in Adult group, was not able to affect the PPR in adult neither in 
young animals.  
Adiporon affects field excitatory post synaptic potential during tetanic stimulation  
Although basal synaptic transmission was never affected by increasing concentrations of ADPO in both age-
groups, we noticed an interesting alteration of fEPSP during tetanus in adult hippocampal slices pre-
incubated with increasing concentrations of ADPO. Notably, fEPSPs amplitude elicited by a high frequency 
tetanic stimulation decreased earlier in slices treated with several ADPO concentrations (1.5, 3, 30 µM) 
compared to control (fig.2C). Thus, we decided to further investigate the ability of ADPO to modulate fEPSP 
during the high frequency tetanic stimulation, which is known to induce in neurons a strong level of 
depolarization which depends on calcium influx (Herron et al., 1986). To this aim, we utilized a modified 
method of analysis (Kuenzi et al., 2000), we measured the AUC (area under the curve) normalised to the 
first fEPSP in each train. This method allows to quantify the level of depolarization of the post-synaptic cell 
during the HFS train which is correlated to the extent of LTP amplitude (Bliss and Collingridge, 1993). Unlike 
paired pulse facilitation, the attenuation of depolarization during HFS was concentration dependent and 
correlated to the degree of LTP attenuation (p > 0.05 at all tested concentrations vs. vehicle; fig.2C). The 
concentration-dependent effect of ADPO on AUC reduction matched the inhibitory effect on LTP and 
strongly suggests that ADPO might exert an effect also through a post-synaptic mechanism.  Taken 
together, these data suggest that ADPO influenced PPR and LTP through different synaptic mechanisms. 
DISCUSSION  
In recent years, adiponectin gained attention in several physiological conditions such as hormonal release 
(Wen et al., 2008; Hoyda et al., 2009; Hoyda and Ferguson, 2010; Mimee et al., 2013), feeding behavior (Qi 
et al., 2004) and neurogenesis (Yau et al., 2014). In addition, preclinical studies pointed out a role in brain 
disorders including depression (Yau et al., 2014), Alzheimer’s disease (Chan et al., 2012; Ali et al., 2015), 
stroke (Song et al., 2013), fear learning (Zhang et al., 2016b) and epilepsy (Lee et al., 2011). These 
pathologies share, to different degrees, a disruption in synaptic plasticity (Ganguly and Poo, 2013). For 
these reasons, we have here investigated whether and how adiponectin receptors activation could 
influence synaptic transmission and plasticity in normal conditions.  
Adiponectin is released in a unique fashion since it is the only protein that increases with weight loss (Wang 
and Scherer, 2016). However, it has been suggested that adiponectin plasmatic level could increase also 
with chronic and acute physical activity (Vuolteenaho et al., 2014). Once adiponectin reaches the 
circulation, it could pass, at least in the trimeric form, the blood-brain barrier (Kusminski et al., 2007; Yau et 
al., 2014). On other hand adiponectin mRNA has been repeatedly detected in central nervous system 
(Rodriguez-Pacheco et al., 2007; Iannitti et al., 2015). Thus, central nervous system could have the 
competence to locally produce and release adiponectin, although it is not clear whether this protein acts 
locally or rather its effect might influence larger numbers of cells and cerebrospinal fluid content. However, 
it is well recognized that both adiponectin receptors are highly expressed in different brain areas; in 
particular the hypothalamus, thalamus, neocortex and hippocampus (Repunte-canonigo et al., 2011; Yau et 
al., 2014).  
In this study we provide the first compelling evidence that a ADPO, a selective agonist for AdipoR1\2 is able 
to influence synaptic plasticity in CA1 hippocampal region in a concentration-dependent fashion. 
Importantly, the dampening effect on LTP was mirrored by a reduction of responses during high frequency 
stimulation despite a preserved basal synaptic transmission.We assume that the concentration-dependent 
dampening effect on LTP relies, mostly, on a post-synaptic mechanism. Indeed, we found a strong decrease 
of fEPSP during the high frequency stimulation protocol that closely mirrors the concentration-dependent 
reduction of LTP. The induction of LTP depends critically on the depolarization of the pyramidal cells, that is 
a function of both excitatory synaptic connections and local GABAergic inhibitory connections (Bliss and 
Collingridge, 1993). The failure to induce LTP does not seem due to lack of excitatory drive as revealed from 
input-output curve. The alteration in PPR could also suggest a presynaptic mechanism but, as 
aforementioned, ADPO effect on paired pulse facilitation was present only at the highest tested 
concentration (30 µM). During the HFS the cell is heavily depolarized, therefore the more attractive 
candidate, which might be influenced by adiponectin receptor activation, is the NMDA receptor because of 
its voltage-dependency. This hypothesis is supported by the reduced efficacy of ADPO observed in younger 
mice that could mirror a developmental change in NMDA receptor subunit expression (Monyer et al., 
1994). Noteworthy, all the above features summarize many of the effects of the NMDA receptor 
antagonists. Indeed, as previously shown in several studies (Herron et al., 1986; Frankiewicz et al., 1996; 
Ribeiro et al., 2014), when NMDA receptor are blocked, the outcome is, invariably, a dampening of high 
frequency responses, mirrored by a reduction in LTP. Moreover NMDA receptor antagonists such as 
ketamine, MK-801, APV, 7-chlorokynurenic acid, induce an age-dependent (Nosyreva et al., 2014) and rapid 
(e.g. 2h) BDNF expression and synaptogenesis (Li et al., 2010; Autry et al., 2011; Gideons et al., 2014; Li et 
al., 2016). In line with this, a recent report showed that  intracerebroventricular injection of adiponectin 
increases synapse number and dendritic complexity in hippocampus (Zhang et al., 2016a). Finally, another 
report suggested a role for adiponectin in the response rate to ketamine in a depressed patient (Machado-
Vieira et al., 2016).  
Thus, ADPO seems to recapitulate many of the electrophysiological features of NMDA receptors blockers, 
thus it might also represent an agent with antidepressive properties like adiponectin itself or several NMDA 
receptors blockers.  
An alternative explanation could be that ADPO induces an initial hyperpolarization of the pyramidal 
neurons that in turn inhibit the activation of NMDAR during HFS. This hypothesis is consistent with a recent 
report about ADPO effect on granule cells of dentate gyrus where this drug caused an hyperpolarization of 
the resting membrane potential (Zhang et al., 2016b). Here we report that ADPO reduces also the paired 
pulse ratio, an effect that could originate from the change of some presynaptic conductances. In line with 
this, Hoyda and collegues, observed sustained outward potassium current elicited by adiponectin in 
hypothalamic neurons. This TEA-sensitive current was able to broaden the action potential (Hoyda and 
Ferguson, 2010). In turn, action potential broadening has, via BK channels, a strong effect on synaptic 
terminals where it can dramatically increase the probability of neurotransmitter release (Deng et al., 2013). 
At the single neuron level, adiponectin receptors activation can either have an excitatory, inhibitory effect 
or neither of two (Hoyda et al., 2009; Hoyda and Ferguson, 2010; Repunte-canonigo et al., 2011). However, 
Osmotin, a natural agonist of adiponectin receptors seems to have an important protective role against 
memory impairment in an Alzheimer’s model mice (Ali et al., 2015). This effect is consistent with the 
protective role of adiponectin in cells which overexpressed amyloid-beta (Chan et al., 2012). Indeed, 
despite their wide range of electrophysiological effects, adiponectin receptors mediate a protective role in 
several in vitro (Qiu et al., 2011; Shah et al., 2014) and in vivo (Nishimura et al., 2008; Jeon et al., 2009;Lee 
et al., 2011; Song et al., 2013) disease paradigms. Interestingly, in some of these studies its protective 
effect seems to be mediated by an active preservation of synaptic integrity that relies on AMPA receptor 
trafficking (Shah et al., 2014; Ali et al., 2015). Thus, it is feasible that many of the beneficial effects could be 
mediated by complex synaptic changes that account also for more general effects, e.g., decreasing severity 
seizure in mice model of epilepsy (Lee et al., 2011). 
In summary, our main finding is a strong reduction of LTP with the highest tested concentration of 
ADPO,albeit the potential mechanisms underlying this effect remains to be investigated. Certainly, data 
here presented suggest for the first time that the adiponectin system, beyond its implication in metabolic 
and inflammatory diseases, plays also a central modulating role at the synapse thereby representing a 
novel target for the treatment of brain diseases.  Importantly, in all aforementioned pathologies, patients 
showed a reduction of serum levels of adiponectin. On the other hand, preclinical evidence strongly 
suggests that increased glutamatergic transmission is a key feature of the above diseases models 
(Gleichmann et al., 2012; Popoli et al., 2012; Casillas-Espinosa et al., 2012; Chao and Li, 2014; Mandolesi et 
al., 2015). Although further experiments are needed to investigate possible detrimental effects of adiporon, 
our data suggest that a replacement therapy with adiponectin or adiporon could have an important impact 
on synaptic function in several pathologies. 
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 Figure legends 
Figure 1. Effects of different concentrations of Adiporon (ADPO; 1.5, 3, 30 μM) on PPR and input-output 
relationship 
A,B, PPR induced by pairs of stimulation delivered at several interstimulus intervals (20, 50, 100, 200, 300, 
500 ms). Data are presented as mean ± SEM. Young group (A), n=5–6 for each ADPO concentration from six 
mice; and adult group (B), n=5–6 for each ADPO concentration from six mice. *p <0.05 vs. the vehicle 
group. 
C,D, Input-output relationship of fEPSPs as a function of presynaptic fiber volley size at the Schaffer 
collateral/CA1 pyramidal cell synapses. Young group (C), n=5–6 separate recordings for each concentration 
from five mice; and adult group (D), n= 5–6 for each concentration from six mice. No significant difference 
was observed between ADPO and vehicle-treated slices. 
Figure 2. Effects of different concentrations of Adiporon (ADPO; 1.5, 3, 30 μM) on CA1-LTP and on fEPSPs 
during tetanus 
A,B,LTP induced by high frequency stimulation (HFS; 100Hz, 1 sec) delivered at Schaffer collaterals. Sample 
traces (above) and summary graph (below) of the averaged time course of LTP. Data are presented as mean 
± SEM. Young group (A), n=5–7 for each ADPO concentration from nine mice; adult group (B), n=7–9 for 
each ADPO concentration from nine mice. *p <0.05 vs. the vehicle group ; **p<0.01 vs. the vehicle group.  
C, fEPSP during tetanus in the adult group. Sample traces (above) show fEPSP during tetanus in the vehicle 
group (left) vs. pre-incubated slice (ADPO, 30 μM) (right). Bar graph (below) representing the overall 
depolarization during tetanus as AUC normalized to the first fEPSP in each train at increasing ADPO 
concentrations.  n=7-9 for each concentration from nine mice. *p <0.05 vs. the vehicle group; **p<0.01 vs. 
the vehicle group. ***p<0.001 vs. the vehicle group. 
 



